OSG OCTAVE SPECIALTY GROUP INC
NYSE · SEC CIK 874501 · EDGAR
- Bought, last 12 months
- $304.8K 3 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 297 since 2021-08-10, latest 2026-07-13 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| LeBlanc Claude | CEO, Dir | $304.6K | — |
| Smith R Sharon | EVP, Group COO | $205 | — |
| Ahn Cristina E. | CAO | — | — |
| McGinnis Daniel | COO, Sr. MD | — | — |
| HAFT IAN DAVID | Dir | — | — |
| Stein Jeffrey Scott | Dir | — | — |
| Matus Kristi Ann | Dir | — | — |
| Ksenak Stephen Michael | GC, Sr. MD | — | — |
| Trick David | EVP, CFO, Treas | — | — |
| PRICE MICHAEL D | Dir | — | — |
Transactions 240
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-13 16:05 | 2026-07-09 | OSG | LeBlanc Claude | CEO, Dir | M - OptEx | — | +39.4K | 1.09M | +4% | — |
| D | 2026-07-13 16:05 | 2026-07-09 | OSG | LeBlanc Claude | CEO, Dir | F - Tax | $6.08 | -21.8K | 1.07M | -2% | -$132.4K |
| D | 2026-07-13 16:04 | 2026-07-09 | OSG | Smith R Sharon | EVP, Group COO | M - OptEx | — | +11.8K | 161.0K | +8% | — |
| D | 2026-07-13 16:04 | 2026-07-09 | OSG | Smith R Sharon | EVP, Group COO | F - Tax | $6.08 | -4,635 | 156.3K | -3% | -$28.2K |
| D | 2026-07-13 16:02 | 2026-07-09 | OSG | Trick David | EVP, CFO, Treas | M - OptEx | — | +13.2K | 273.8K | +5% | — |
| D | 2026-07-13 16:02 | 2026-07-09 | OSG | Trick David | EVP, CFO, Treas | F - Tax | $6.08 | -6,741 | 267.1K | -2% | -$41.0K |
| D | 2026-03-25 | 2026-03-10 | OSG | Ahn Cristina E. | CAO | M - OptEx | — | +835 | 835 | New | — |
| D | 2026-03-25 | 2026-03-10 | OSG | Ahn Cristina E. | CAO | F - Tax | $4.90 | -203 | 632 | -24% | -$994.70 |
| D | 2026-03-05 | 2026-03-03 | OSG | LeBlanc Claude | CEO, Dir | M - OptEx | $0.00 | +24.5K | 1.06M | +2% | $0 |
| D | 2026-03-05 | 2026-03-03 | OSG | LeBlanc Claude | CEO, Dir | F - Tax | $5.60 | -10.7K | 1.05M | -1% | -$59.9K |
| D | 2026-03-05 | 2026-03-03 | OSG | Smith R Sharon | EVP, Group COO | M - OptEx | $0.00 | +1,541 | 150.7K | +1% | $0 |
| D | 2026-03-05 | 2026-03-03 | OSG | Smith R Sharon | EVP, Group COO | F - Tax | $5.60 | -1,541 | 149.2K | -1% | -$8,630 |
| D | 2026-03-05 | 2026-03-03 | OSG | Trick David | EVP, CFO, Treas | M - OptEx | $0.00 | +1,715 | 262.3K | +0.7% | $0 |
| D | 2026-03-05 | 2026-03-03 | OSG | Trick David | EVP, CFO, Treas | F - Tax | $5.60 | -1,715 | 260.6K | -0.7% | -$9,604 |
| DA | 2026-03-03 | 2025-09-30 | OSG | Trick David | EVP, CFO, Treas | M - OptEx | $0.00 | +42.5K | 283.4K | +18% | $0 |
| DMA | 2026-03-03 | 2025-09-29+ | OSG | Trick David | EVP, CFO, Treas | F - Tax | $9.42 | -103.3K | 240.9K | -30% | -$972.9K |
| DA | 2026-03-03 | 2025-09-29 | OSG | Trick David | EVP, CFO, Treas | C - Cnv Deriv | $0.00 | +165.4K | 321.4K | +106% | $0 |
| DMA | 2026-03-03 | 2025-09-29+ | OSG | Smith R Sharon | EVP, Group COO | F - Tax | $9.66 | -73.9K | 149.2K | -33% | -$714.0K |
| DA | 2026-03-03 | 2025-09-29 | OSG | Smith R Sharon | EVP, Group COO | C - Cnv Deriv | $0.00 | +145.1K | 219.8K | +194% | $0 |
| DA | 2026-03-03 | 2025-09-30 | OSG | Smith R Sharon | EVP, Group COO | M - OptEx | $0.00 | +3,235 | 152.4K | +2% | $0 |
| 2026-01-05 | 2026-01-02 | OSG | LeBlanc Claude | CEO, Dir | P - Purchase | $7.59 | +12.0K | 1.03M | +1% | +$91.1K | |
| 2025-11-14 | 2025-11-12 | OSG | Smith R Sharon | EVP, Group COO | P - Purchase | $10.25 | +20 | 171.0K | +0.0% | +$205 | |
| D | 2025-10-01 | 2025-09-29 | OSG | Ksenak Stephen Michael | GC, Sr. MD | F - Tax | $9.72 | -43.5K | 205.3K | -17% | -$423.0K |
| D | 2025-10-01 | 2025-09-29 | OSG | Ksenak Stephen Michael | GC, Sr. MD | C - Cnv Deriv | $0.00 | +129.1K | 248.8K | +108% | $0 |
| D | 2025-10-01 | 2025-09-29 | OSG | McGinnis Daniel | COO, Sr. MD | F - Tax | $9.72 | -10.1K | 38.2K | -21% | -$97.7K |
| D | 2025-10-01 | 2025-09-29 | OSG | McGinnis Daniel | COO, Sr. MD | C - Cnv Deriv | $0.00 | +29.8K | 48.3K | +162% | $0 |
| D | 2025-10-01 | 2025-09-29 | OSG | Trick David | EVP, CFO, Treas | C - Cnv Deriv | $0.00 | +165.4K | 321.4K | +106% | $0 |
| DM | 2025-10-01 | 2025-09-29+ | OSG | Trick David | EVP, CFO, Treas | F - Tax | $9.41 | -72.1K | 291.8K | -20% | -$678.6K |
| D | 2025-10-01 | 2025-09-30 | OSG | Trick David | EVP, CFO, Treas | M - OptEx | $0.00 | +42.5K | 308.2K | +16% | $0 |
| D | 2025-10-01 | 2025-09-29 | OSG | Smith R Sharon | EVP, Chief Strategy Offr | C - Cnv Deriv | $0.00 | +145.1K | 219.8K | +194% | $0 |
| DM | 2025-10-01 | 2025-09-29+ | OSG | Smith R Sharon | EVP, Chief Strategy Offr | F - Tax | $9.64 | -51.7K | 170.9K | -23% | -$498.9K |
| D | 2025-10-01 | 2025-09-30 | OSG | Smith R Sharon | EVP, Chief Strategy Offr | M - OptEx | $0.00 | +2,814 | 173.7K | +2% | $0 |
| DM | 2025-10-01 | 2025-09-29+ | OSG | LeBlanc Claude | CEO, Dir | F - Tax | $9.39 | -461.2K | 996.8K | -32% | -$4.33M |
| D | 2025-10-01 | 2025-10-01 | OSG | LeBlanc Claude | CEO, Dir | P - Purchase | $8.54 | +25.0K | 1.02M | +3% | +$213.5K |
| D | 2025-10-01 | 2025-09-30 | OSG | LeBlanc Claude | CEO, Dir | M - OptEx | $0.00 | +193.4K | 1.11M | +21% | $0 |
| D | 2025-10-01 | 2025-09-29 | OSG | LeBlanc Claude | CEO, Dir | C - Cnv Deriv | $0.00 | +661.4K | 1.26M | +110% | $0 |
| D | 2025-09-30 | 2025-09-29 | OSG | Stein Jeffrey Scott | Dir | C - Cnv Deriv | $0.00 | +167.8K | 217.8K | +336% | $0 |
| D | 2025-09-30 | 2025-09-29 | OSG | PRICE MICHAEL D | Dir | C - Cnv Deriv | $0.00 | +39.2K | 205.5K | +24% | $0 |
| D | 2025-09-30 | 2025-09-29 | OSG | HAFT IAN DAVID | Dir | C - Cnv Deriv | — | +131.9K | 131.9K | New | — |
| D | 2025-09-30 | 2025-09-29 | OSG | IGLESIAS LISA G | Dir | C - Cnv Deriv | $0.00 | +67.8K | 82.3K | +466% | $0 |
| D | 2025-09-30 | 2025-09-29 | OSG | LAMMTENNANT JOAN M | Dir | C - Cnv Deriv | $0.00 | +107.0K | 107.0K | New | $0 |
| D | 2025-09-30 | 2025-09-29 | OSG | Matus Kristi Ann | Dir | C - Cnv Deriv | $0.00 | +39.2K | 48.2K | +435% | $0 |
| 2025-08-11 | 2025-08-11 | OSG | LeBlanc Claude | CEO, Dir | P - Purchase | $7.03 | +25.0K | 603.3K | +4% | +$175.8K | |
| M | 2025-05-15 | 2025-05-14 | OSG | Stein Jeffrey Scott | Dir | P - Purchase | $6.46 | +15.0K | 50.0K | +43% | +$96.9K |
| M | 2025-05-14 | 2025-05-14 | OSG | PRICE MICHAEL D | Dir | P - Purchase | $6.49 | +77.0K | 166.2K | +86% | +$499.6K |
| 2025-05-14 | 2025-05-14 | OSG | LeBlanc Claude | CEO, Dir | P - Purchase | $6.50 | +40.0K | 578.3K | +7% | +$260.0K | |
| D | 2025-03-14 | 2025-03-13 | OSG | BARRANCO DAVID | Senior Managing Dir | F - Tax | $8.39 | -189 | 128.4K | -0.1% | -$1,586 |
| D | 2025-03-14 | 2025-03-13 | OSG | BARRANCO DAVID | Senior Managing Dir | M - OptEx | $0.00 | +189 | 128.6K | +0.1% | $0 |
| D | 2025-03-14 | 2025-03-13 | OSG | Trick David | EVP, CFO, Treas | F - Tax | $8.39 | -267 | 156.3K | -0.2% | -$2,240 |
| D | 2025-03-14 | 2025-03-13 | OSG | Trick David | EVP, CFO, Treas | M - OptEx | $0.00 | +267 | 156.3K | +0.2% | $0 |
| D | 2025-03-14 | 2025-03-13 | OSG | McGinnis Daniel | COO, Sr. MD | F - Tax | $8.39 | -94 | 18.5K | -0.5% | -$788.66 |
| D | 2025-03-14 | 2025-03-13 | OSG | McGinnis Daniel | COO, Sr. MD | M - OptEx | $0.00 | +94 | 18.6K | +0.5% | $0 |
| D | 2025-03-14 | 2025-03-13 | OSG | Eisman Robert Bryan | CAO, Sr. MD | F - Tax | $8.39 | -687 | 70.1K | -1.0% | -$5,764 |
| D | 2025-03-14 | 2025-03-13 | OSG | Eisman Robert Bryan | CAO, Sr. MD | M - OptEx | $0.00 | +1,908 | 70.8K | +3% | $0 |
| D | 2025-03-14 | 2025-03-13 | OSG | Ksenak Stephen Michael | GC, Sr. MD | F - Tax | $8.39 | -1,703 | 121.6K | -1% | -$14.3K |
| D | 2025-03-14 | 2025-03-13 | OSG | Ksenak Stephen Michael | GC, Sr. MD | M - OptEx | $0.00 | +4,726 | 123.3K | +4% | $0 |
| D | 2025-03-14 | 2025-03-13 | OSG | LeBlanc Claude | CEO, Dir | M - OptEx | $0.00 | +24.3K | 551.7K | +5% | $0 |
| D | 2025-03-14 | 2025-03-13 | OSG | LeBlanc Claude | CEO, Dir | F - Tax | $8.39 | -13.5K | 538.3K | -2% | -$112.9K |
| D | 2025-03-14 | 2025-03-13 | OSG | Smith R Sharon | EVP, Chief Strategy Offr | M - OptEx | $0.00 | +238 | 74.9K | +0.3% | $0 |
| D | 2025-03-14 | 2025-03-13 | OSG | Smith R Sharon | EVP, Chief Strategy Offr | F - Tax | $8.39 | -238 | 74.7K | -0.3% | -$1,997 |
| D | 2025-03-10 | 2025-03-06 | OSG | BARRANCO DAVID | Senior Managing Dir | A - Grant | $0.00 | +17.5K | 135.8K | +15% | $0 |
| D | 2025-03-10 | 2025-03-06 | OSG | BARRANCO DAVID | Senior Managing Dir | F - Tax | $9.16 | -7,379 | 128.4K | -5% | -$67.6K |
| D | 2025-03-10 | 2025-03-06 | OSG | LeBlanc Claude | CEO, Dir | A - Grant | $0.00 | +10.8K | 538.2K | +2% | $0 |
| D | 2025-03-10 | 2025-03-06 | OSG | LeBlanc Claude | CEO, Dir | F - Tax | $9.16 | -10.8K | 527.4K | -2% | -$99.0K |
| D | 2025-03-10 | 2025-03-06 | OSG | Eisman Robert Bryan | CAO, Sr. MD | F - Tax | $9.16 | -1,271 | 68.9K | -2% | -$11.6K |
| D | 2025-03-10 | 2025-03-06 | OSG | Eisman Robert Bryan | CAO, Sr. MD | M - OptEx | $0.00 | +1,271 | 68.9K | +2% | $0 |
| D | 2025-03-10 | 2025-03-06 | OSG | Trick David | EVP, CFO, Treas | M - OptEx | $0.00 | +2,446 | 158.5K | +2% | $0 |
| D | 2025-03-10 | 2025-03-06 | OSG | Trick David | EVP, CFO, Treas | F - Tax | $9.16 | -2,446 | 156.1K | -2% | -$22.4K |
| D | 2025-03-10 | 2025-03-06 | OSG | Ksenak Stephen Michael | GC, Sr. MD | F - Tax | $9.16 | -1,967 | 118.6K | -2% | -$18.0K |
| D | 2025-03-10 | 2025-03-06 | OSG | Ksenak Stephen Michael | GC, Sr. MD | M - OptEx | $0.00 | +1,967 | 118.6K | +2% | $0 |
| D | 2025-03-10 | 2025-03-06 | OSG | Smith R Sharon | EVP, Chief Strategy Offr | M - OptEx | $0.00 | +2,154 | 76.9K | +3% | $0 |
| D | 2025-03-10 | 2025-03-06 | OSG | Smith R Sharon | EVP, Chief Strategy Offr | F - Tax | $9.16 | -2,154 | 74.7K | -3% | -$19.7K |
| D | 2025-03-10 | 2025-03-06 | OSG | McGinnis Daniel | COO, Sr. MD | M - OptEx | $0.00 | +16.9K | 25.2K | +203% | $0 |
| D | 2025-03-10 | 2025-03-06 | OSG | McGinnis Daniel | COO, Sr. MD | F - Tax | $9.16 | -6,736 | 18.5K | -27% | -$61.7K |
| DM | 2025-03-04 | 2025-02-28+ | OSG | McGinnis Daniel | COO, Sr. MD | F - Tax | $9.51 | -630 | 8,318 | -7% | -$5,994 |
| DM | 2025-03-04 | 2025-02-28+ | OSG | McGinnis Daniel | COO, Sr. MD | M - OptEx | — | +630 | 8,648 | +8% | — |
| DM | 2025-03-04 | 2025-02-28+ | OSG | Smith R Sharon | EVP, Chief Strategy Offr | F - Tax | $9.52 | -1,173 | 74.7K | -2% | -$11.2K |
| DM | 2025-03-04 | 2025-02-28+ | OSG | Smith R Sharon | EVP, Chief Strategy Offr | M - OptEx | — | +1,173 | 75.2K | +2% | — |
| DM | 2025-03-04 | 2025-02-28+ | OSG | BARRANCO DAVID | Senior Managing Dir | F - Tax | $9.52 | -4,469 | 118.3K | -4% | -$42.5K |
| DM | 2025-03-04 | 2025-02-28+ | OSG | BARRANCO DAVID | Senior Managing Dir | M - OptEx | — | +10.9K | 120.4K | +10% | — |
| DM | 2025-03-04 | 2025-02-28+ | OSG | Trick David | EVP, CFO, Treas | F - Tax | $9.61 | -864 | 156.1K | -0.6% | -$8,307 |
| DM | 2025-03-04 | 2025-02-28+ | OSG | Trick David | EVP, CFO, Treas | M - OptEx | — | +864 | 156.3K | +0.6% | — |
| DM | 2025-03-04 | 2025-02-28+ | OSG | Ksenak Stephen Michael | GC, Sr. MD | M - OptEx | — | +982 | 117.0K | +0.8% | — |
| DM | 2025-03-04 | 2025-02-28+ | OSG | Ksenak Stephen Michael | GC, Sr. MD | F - Tax | $9.54 | -982 | 116.6K | -0.8% | -$9,371 |
| DM | 2025-03-04 | 2025-02-28+ | OSG | Eisman Robert Bryan | CAO, Sr. MD | M - OptEx | — | +445 | 67.8K | +0.7% | — |
| DM | 2025-03-04 | 2025-02-28+ | OSG | Eisman Robert Bryan | CAO, Sr. MD | F - Tax | $9.51 | -445 | 67.6K | -0.7% | -$4,234 |
| DM | 2025-03-04 | 2025-02-28+ | OSG | LeBlanc Claude | CEO, Dir | M - OptEx | — | +2,040 | 528.3K | +0.4% | — |
| DM | 2025-03-04 | 2025-02-28+ | OSG | LeBlanc Claude | CEO, Dir | F - Tax | $9.53 | -2,040 | 527.4K | -0.4% | -$19.4K |
| M | 2024-09-27 | 2024-09-26+ | OSG | Matus Kristi Ann | Dir | P - Purchase | $11.19 | +9,000 | 9,000 | New | +$100.7K |
| 2024-08-08 | 2024-08-07 | OSG | Stein Jeffrey Scott | Dir | P - Purchase | $10.82 | +25.0K | 35.0K | +250% | +$270.5K | |
| 2024-08-08 | 2024-08-08 | OSG | Smith R Sharon | EVP, Chief Strategy Offr | P - Purchase | $10.64 | +1,100 | 74.7K | +1% | +$11.7K | |
| M | 2024-08-08 | 2024-08-07 | OSG | Trick David | EVP, CFO, Treas | P - Purchase | $10.76 | +3,700 | 156.1K | +2% | +$39.8K |
| 2024-08-08 | 2024-08-07 | OSG | Ksenak Stephen Michael | GC, Sr. MD | P - Purchase | $11.00 | +5,000 | 116.6K | +4% | +$55.0K | |
| M | 2024-08-08 | 2024-08-07 | OSG | PRICE MICHAEL D | Dir | P - Purchase | $11.19 | +89.3K | 4,735 | New | +$999.5K |
| M | 2024-08-08 | 2024-08-07 | OSG | LeBlanc Claude | CEO, Dir | P - Purchase | $10.83 | +25.0K | 526.7K | +5% | +$270.9K |
| D | 2024-03-11 | 2024-03-08 | OSG | Trick David | EVP, CFO, Treas | M - OptEx | $0.00 | +270 | 152.7K | +0.2% | $0 |
| D | 2024-03-11 | 2024-03-08 | OSG | Trick David | EVP, CFO, Treas | F - Tax | $15.38 | -270 | 152.4K | -0.2% | -$4,153 |
| D | 2024-03-11 | 2024-03-08 | OSG | LeBlanc Claude | CEO, Dir | M - OptEx | $0.00 | +1,193 | 503.6K | +0.2% | $0 |
| D | 2024-03-11 | 2024-03-08 | OSG | LeBlanc Claude | CEO, Dir | F - Tax | $15.38 | -1,193 | 502.4K | -0.2% | -$18.3K |
| D | 2024-03-11 | 2024-03-08 | OSG | Eisman Robert Bryan | CAO, Sr. MD | F - Tax | $15.38 | -87 | 67.6K | -0.1% | -$1,338 |
Purchase Sale Sale after option exercise All abbreviations